teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 7 Projects Releases Packages Wiki Activity Actions 1

extract: 2024-xx-ajpm-cvd-mortality-trends-2010-2022-update-final-data
Some checks are pending
Sync Graph Data to teleo-app / sync (push) Waiting to run
Details

Browse source 
Pentagon-Agent: Epimetheus <3D35839A-7722-4740-B93D-51157F7D5E70>
This commit is contained in:
Teleo Agents 2026-03-31 04:33:39 +00:00
parent a606243fd6
commit 41abf0332f
2 changed files with 20 additions and 1 deletions
Show stats Download patch file Download diff file Expand all files Collapse all files

6
domains/health/hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure.md
View file

@ -25,6 +25,12 @@ This provides the strongest single empirical case for the claim that medical car
--- ---
### Additional Evidence (extend)
*Source: [[2024-xx-ajpm-cvd-mortality-trends-2010-2022-update-final-data]] | Added: 2026-03-31*
US CVD age-adjusted mortality rate in 2022 returned to 2012 levels (434.6 per 100,000 for adults ≥35), erasing a decade of progress. Adults aged 35-54 experienced elimination of the preceding decade's CVD gains from 2019-2022, with 228,524 excess CVD deaths 2020-2022 (9% above expected). The midlife pattern is inconsistent with COVID harvesting (which primarily affects the frail elderly) and suggests structural disease load.
Relevant Notes: Relevant Notes:
- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]] - [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]
- [[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]] - [[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]

15
inbox/queue/2024-xx-ajpm-cvd-mortality-trends-2010-2022-update-final-data.md
View file

@ -7,9 +7,13 @@ date: 2024-09-01
domain: health domain: health
secondary_domains: [] secondary_domains: []
format: article format: article
status: unprocessed status: enrichment
priority: high priority: high
tags: [CVD-mortality, cardiovascular, stagnation, midlife, working-age, excess-deaths, COVID, 2010-2022, AJPM] tags: [CVD-mortality, cardiovascular, stagnation, midlife, working-age, excess-deaths, COVID, 2010-2022, AJPM]
processed_by: vida
processed_date: 2026-03-31
enrichments_applied: ["hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure.md"]
extraction_model: "anthropic/claude-sonnet-4.5"
--- ---
## Content ## Content
@ -79,3 +83,12 @@ PRIMARY CONNECTION: `hypertension-related-cvd-mortality-doubled-2000-2023-despit
WHY ARCHIVED: Closes the COVID harvesting test thread. Confirms the 2022 CVD AAMR is at 2012 levels with the 35-54 age group showing full decade erasure — key evidence for structural vs. transient interpretation of CVD stagnation. WHY ARCHIVED: Closes the COVID harvesting test thread. Confirms the 2022 CVD AAMR is at 2012 levels with the 35-54 age group showing full decade erasure — key evidence for structural vs. transient interpretation of CVD stagnation.
EXTRACTION HINT: This is a data update to the stagnation cluster, not a new standalone claim. The extractor should enrich the existing stagnation claims with the midlife 35-54 "decade of gains erased" finding. The PNAS "double jeopardy" framing (older-age more numerically significant than midlife) should be noted as a scope qualifier. EXTRACTION HINT: This is a data update to the stagnation cluster, not a new standalone claim. The extractor should enrich the existing stagnation claims with the midlife 35-54 "decade of gains erased" finding. The PNAS "double jeopardy" framing (older-age more numerically significant than midlife) should be noted as a scope qualifier.
## Key Facts
- CVD AAMR declined 8.9% from 2010 to 2019 (456.6 → 413.0 per 100,000)
- CVD AAMR increased 9.3% from 2019 to 2022 to 454.5 per 100,000
- 2022 CVD AAMR for adults ≥35 was 434.6 per 100,000, matching 2012 levels (434.7)
- 228,524 excess CVD deaths occurred 2020-2022, representing 9% above expected
- All-cause mortality AAMR decreased 6.0% from 2022 to 2023 (798.8 → 750.5 per 100,000)
- PNAS 2023 companion paper describes US experiencing 'double jeopardy' driven more by older-age than midlife mortality numerically